Jeanette Leusen, PhDAssociate Professor, Head Immunotherapy Group at University Medical Center Utrecht
Jeanette Leusen received her PhD in 1995 at the University of Amsterdam (UvA), The Netherlands, and is now PI of the Immunotherapy research group (15 FTE) of the Center for Translational Immunology of the University Medical Center Utrecht. In the last 20 years Dr Leusen investigated FcR biology and the potential of IgA as a therapeutic antibody. She has co-authored about 110 peer-reviewed papers and is lead inventor on 5 patents concerning IgA. Since 2012 she is also head of the UMAB facility for antibody generation, and in 2018 she founded the spin-off company TigaTx, that is dedicated to proceed with engineered IgA towards the clinic.